Commentary

There is a good way to do drug and vax safety surveillance, which has been in place for decades and that program is assessing CV-19 vax safety.

Apparently I have nothing better to do with my life than read CV-19 research, kind of like a really bad addiction.

Our Governor wants to put us in a position were we have no reliable source of electricity and pay a fortune for it.

Come meet the candidate we need to defeat our dreadful Governor.

Yet another in our apparently endless series of research summaries.

Today's inflation report shows the continued deadly effect of the Dems spending sprees; you can't print all that money without consequences.

An ongoing look at rate trends by age group.

The latest in our series looking at the age impact of the epidemic.

Our incompetent, mentally and from the standpoint of being up to the job, president is endangering our national security by using the Strategic Petroleum Reserve for political purposes.

Meet the new research summaries, same as the old research summaries.

A thank you to readers, a note about comments, particularly on vax safety.

In the very oldest adults, both basic vaccination and a booster appear to have a beneficial reduction of risk.

Updated breakthrough data for the 12 to 17 group, where the vax are also useless.

Older adults also get some protection against hospitalization from the vax.

For young adults to middle-aged ones, the vax doesn't protect against infection but does seem to reduce hospitalization risk somewhat.